Patients who responded to ICP-lowering treatment had a 64% lower risk of death at 2 weeks than those who did not respond after adjusting for factors that independently predict risk of death.
No takes yet. Share an insight, caveat, or question.
Farahvar et al. (2011) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: